Search Results
Results found for "Analisa Thompson Gray"
Posts (26)
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
The Legacy of Schild Analysis Schild analysis was born from an elegantly simple equation published by At its heart, Schild analysis isn’t about math—it’s about validation. Partial agonists don’t break Schild analysis—they refine it. Schild analysis still applies—if used carefully. Schild analysis translates that language.
- How Schild Analysis Protects Your Conclusions in GPCR Research
Schild analysis is one of the few tools that tells you whether your “competitive antagonist” is actually Terry’s Corner: Schild Analysis — Why It Matters Most assays show a clean rightward shift and we assume Kenakin breaks down why Schild analysis remains the gold standard for verifying true competition — and Gives You an Edge Premium delivers a clear, noise-free stream of GPCR intelligence every week: deeper analysis
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
How Fluorescent Ligands Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional
Other Pages (13)
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
Ceddia 1, *, Zack Zurawski 2,3,*, Analisa Thompson Gray 2, Feyisayo Adegboye 2, Ainsley McDonald-Boyer This is one of the top Pharmacology departments in the country, judged by reputation, citation analysis
- Advanced data analysis for GPCR pharmacology | Dr. GPCR Ecosystem
Advanced data analysis for GPCR pharmacology Dr.
- Translating computational approaches to GPCR biologists with Dr. Riccardo Capelli | Dr. GPCR Ecosystem
followed by a postdoctoral role at the Polytechnic University of Turin (Italy), where he developed coarse-grained
